内蒙古医科大学学报
內矇古醫科大學學報
내몽고의과대학학보
Journal of Inner Mongolia Medical University
2014年
4期
318-321
,共4页
鲍曼不动杆菌%呼吸道感染%耐药性%抗菌药物
鮑曼不動桿菌%呼吸道感染%耐藥性%抗菌藥物
포만불동간균%호흡도감염%내약성%항균약물
Acinetobacter baumannii%lower respiratory tract infection%drug resistance%antibiotics
目的：了解我院鲍曼不动杆菌的感染分布与耐药情况，为临床治疗提供依据。方法：对住院病人送检样本中培养分离出的825株鲍曼不动杆菌的感染分布与耐药情况进行分析。采用稀释法进行药物敏感试验，结果按CLSI标准判定。结果：鲍曼不动杆菌主要分布在重症监护病房( ICU )和呼吸科，主要来自痰标本(90.6%)，对丁胺卡那霉素的耐药率最低(16.28%)，其次为亚胺培南(31.25%)，对其他19种抗菌药物的耐药率均较高。结论：鲍曼不动杆菌主要引起呼吸道感染，对现有多种抗菌药物耐药严重，提示临床医师必须对该菌所致感染予以高度重视。
目的：瞭解我院鮑曼不動桿菌的感染分佈與耐藥情況，為臨床治療提供依據。方法：對住院病人送檢樣本中培養分離齣的825株鮑曼不動桿菌的感染分佈與耐藥情況進行分析。採用稀釋法進行藥物敏感試驗，結果按CLSI標準判定。結果：鮑曼不動桿菌主要分佈在重癥鑑護病房( ICU )和呼吸科，主要來自痰標本(90.6%)，對丁胺卡那黴素的耐藥率最低(16.28%)，其次為亞胺培南(31.25%)，對其他19種抗菌藥物的耐藥率均較高。結論：鮑曼不動桿菌主要引起呼吸道感染，對現有多種抗菌藥物耐藥嚴重，提示臨床醫師必鬚對該菌所緻感染予以高度重視。
목적：료해아원포만불동간균적감염분포여내약정황，위림상치료제공의거。방법：대주원병인송검양본중배양분리출적825주포만불동간균적감염분포여내약정황진행분석。채용희석법진행약물민감시험，결과안CLSI표준판정。결과：포만불동간균주요분포재중증감호병방( ICU )화호흡과，주요래자담표본(90.6%)，대정알잡나매소적내약솔최저(16.28%)，기차위아알배남(31.25%)，대기타19충항균약물적내약솔균교고。결론：포만불동간균주요인기호흡도감염，대현유다충항균약물내약엄중，제시림상의사필수대해균소치감염여이고도중시。
Objective:To investigate the clinical distribution and drug resistance of Acinetobacter baumannii in order to offer basis for the clinical therapeutics. Methods:Analyze the infection distribution and drug resistance of 825 samples of Acinetobacter baumannii that were isolated from various kinds of specimens from inpatients. The drug sensitivity test was done by means of dilution,and then the results were assessed with CLSI ( Clinical and Laboratory Standards Institute ) . Results:Acinetobacter baumannii samples were mainly distributed in ICU ward and Respiration department. The highest positive rate of Acinetobacter baumannii was in sputum ( 90 . 6%) . The resistance rates to Amikacin(16.28%). were the lowest,and to Imipenem(31.25%)came to be next. Acinetobacter baumannii were high resistant to other 19 tested antibiotics. Conclusions:Acinetobacter baumannii is a common pathogen of respiratory tract infection,which has a high resistance rate to the current clinical antibacterial agents. Consequently, clinical doctors should attach more importance to the infection resulted from Acinetobacter Baumannii.
